DOI : https://doi.org/10.56338/mppki.v6i5.3355

Kesediaan Vaksinasi dan Kesediaan Bayar Vaksinasi Booster Covid 19 : Literature Review Willingness to Vacinate dan Willingness to Pay Vaksinasi Booster Covid19 : Literature Review

Ias Tarina Puspitasari (1), Ascobat Gani (2)
(1) Program Studi Ilmu Kesehatan Masyarakat, Fakultas Kesehatan Masyarakat, Universitas Indonesia, Depok 16424, Indonesia
(2) Departemen Administrasi dan Kebijakan Kesehatan Fakultas Kesehatan Masyarakat Universitas Indonesia, Depok 16424, Indonesia
Fulltext View | Download
How to cite :
Puspitasari, I. T. ., & Ascobat Gani. (2023). Kesediaan Vaksinasi dan Kesediaan Bayar Vaksinasi Booster Covid 19 : Literature Review: Willingness to Vacinate dan Willingness to Pay Vaksinasi Booster Covid19 : Literature Review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 6(5), 831–842. https://doi.org/10.56338/mppki.v6i5.3355
Citation Format :

Latar Belakang : Capaian vaksinasi booster masih belum mencapai cakupan yang optimal. Cakupan vaksinasi booster (dosis 3) di Indonesia masih terbilang cukup rendah yaitu sekitar 29.83%. Pelaksanaan program vaksinasi booster memberikan banyak tantangan. Di antaranya yang sangat penting menyangkut pertanyaan apakah masyarakat mau menerima dan mau membeli vaksin tersebut apabila diperlukan.


Tujuan : Penelitian ini bertujuan untuk mengidentifikasi faktor penting yang mempengaruhi kesediaan masyarakat untuk menerima dan membayar vaksinasi booster Covid19.


Metode: Tinjauan sistematik menggunakan panduan PRISMA (Preferred Reporting Items for Systematic Review or Meta-Analysis). Pencarian data menggunakan search engine yaitu Pubmed, ScienceDirect, Embase dan Scopus mulai tahun 2021 sampai dengan tahun 2022. Penulis menggunakan kriteria inklusi dan eksklusi untuk mengidentifikasi studi yang akan direviu. Ditemukan 22 studi yang memenuhi kriteria inklusi.


Hasil: Sebagian besar studi menunjukkan hasil bahwa responden bersedia untuk menerima vaksinasi booster (> 60%) dan satu studi yang menunjukkan hasil yang rendah yaitu < 50%. Beberapa studi menunjukkan kesediaan responden untuk membayar vaksinasi booster, yaitu <RM50, Mean 109 – 189 CNY, 0-300 CNY, dan <100 - ≥500 CNY. Kesediaan untuk menerima dan membayar vaksinasi booster dipengaruhi oleh faktor sosio-demografi, faktor persepsi individu dan faktor eksternal berupa kebijakan dari pemerintah maupun saran dari tenaga kesehatan.


Kesimpulan: Temuan studi dapat memberikan informasi bagi pembuat kebijakan untuk merancang program vaksinasi dan skema keuangan yang lebih baik di masa depan. Dukungan keuangan tetap diperlukan untuk sebagian masyarakat yang kurang mampu dari sisi ekonomi.


 


 

  1. Cerda AA, García LY. Willingness to Pay for a COVID-19 Vaccine. Appl Health Econ Health Policy [Internet]. 2021;19(3):343–51. Available from: https://doi.org/10.1007/s40258-021-00644-6
  2. Nieuwlaat R, Mbuagbaw L, Mertz D, Burrows LL, Bowdish DME, Moja L, et al. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies. Clin Infect Dis. 2021;72(9):1657–9.
  3. Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9(2).
  4. Lurie N. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med [Internet]. 2020;108(1):1969–73. Available from: nejm.org
  5. Fan Y-J, Chan K-H, Hung IF. Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3. Vol. 9, Vaccines. 2021.
  6. Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet [Internet]. 2022;399(10328):924–44. Available from: http://dx.doi.org/10.1016/S0140-6736(22)00152-0
  7. Ewen Callaway. COVID vaccine boosters: the most important questions. Nature [Internet]. 2021; Available from: https://www.nature.com/articles/d41586-021-02158-6
  8. Hou Z, Jie Chang, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine [Internet]. 2014;32(35):4471–7. Available from: https://www.sciencedirect.com/science/article/pii/S0264410X14008482
  9. Harapan H, Fajar JK, Sasmono RT, Kuch U. Dengue vaccine acceptance and willingness to pay. Hum Vaccines Immunother [Internet]. 2017;13(4):786–90. Available from: http://dx.doi.org/10.1080/21645515.2016.1259045
  10. Ughasoro MD, Esangbedo DO, Tagbo BN, Mejeha IC. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):1–15.
  11. Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, et al. National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine - April 1 to December 8, 2020. JAMA - J Am Med Assoc. 2021;325(4):396–8.
  12. Kementerian Kesehatan Republik Indonesia. Vaksinasi COVID-19 Nasional [Internet]. Status Vaksin. 2023 [cited 2023 Jan 26]. Available from: https://vaksin.kemkes.go.id/#/vaccines
  13. Hynes S, Armstrong CW, Xuan BB, Ankamah-Yeboah I, Simpson K, Tinch R, et al. Have environmental preferences and willingness to pay remained stable before and during the global Covid-19 shock? Ecol Econ J Int Soc Ecol Econ. 2021 Nov;189:107142.
  14. Rodrigues CMC, Plotkin SA. Impact of Vaccines; Health, Economic and Social Perspectives. Front Microbiol. 2020;11.
  15. Bartsch SM, Wedlock PT, O’Shea KJ, Cox SN, Strych U, Nuzzo JB, et al. Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination. J Infect Dis. 2021;224(6):938–48.
  16. Kohli M, Maschio M, Becker D, Weinstein MC. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine [Internet]. 2021;39(7):1157–64. Available from: https://doi.org/10.1016/j.vaccine.2020.12.078
  17. Wu F, Yuan Y, Deng Z, Yin D, Shen Q, Zeng J, et al. Acceptance of COVIDâ€19 booster vaccination based on the protection motivation theory: A crossâ€sectional study in China. J Med Virol [Internet]. 2022 Sep 9;94(9):4115–24. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jmv.27825
  18. Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, et al. Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India. Vaccines [Internet]. 2022 Jun 30;10(7):1048. Available from: https://www.mdpi.com/2076-393X/10/7/1048
  19. Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, et al. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece. Vaccines [Internet]. 2022 Jun 30;10(7):1061. Available from: https://www.mdpi.com/2076-393X/10/7/1061
  20. Tan KYK, Soh ASE, Ong BWL, Chen MIC, Griva K. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series. Vaccines. 2022;10(7).
  21. Abouzid M, Ahmed AA, El-Sherif DM, Alonazi WB, Eatmann AI, Alshehri MM, et al. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants. Vaccines [Internet]. 2022 Aug 6;10(8):1270. Available from: https://www.mdpi.com/2076-393X/10/8/1270
  22. Lin Y, Huang Z, Xu X, Du W, Alias H, Hu Z, et al. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China. Hum Vaccin Immunother [Internet]. 2022 Nov 30;18(6):2126667. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2126667
  23. Rzymski P, Poniedziałek B, Fal A. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland. Vaccines [Internet]. 2021 Nov 5;9(11):1286. Available from: https://www.mdpi.com/2076-393X/9/11/1286
  24. Aw J, Jie J, Seng B, Si S, Seah Y, Low LL. COVID-19 Vaccine Hesitancy — A Scoping Review of Literature in High-Income Countries. 2021;2019(December 2019).
  25. Mueangpoon K, Inchan C, Kaewmuneechoke P, Rattana P, Budsratid S, Japakiya S, et al. Self-Reported COVID-19 Vaccine Hesitancy and Willingness to Pay: A Cross-Sectional Survey in Thailand. Vaccines [Internet]. 2022 Apr 16;10(4):627. Available from: https://www.mdpi.com/2076-393X/10/4/627
  26. Acharya D, Budhathoki CB, Khanal SP. Factors associated to acceptance and willingness to pay for COVID vaccine in Nepal. J Prev Med Hyg [Internet]. 2022 Jun;63(2):E240–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35968064
  27. Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother [Internet]. 2021 Jun 3;17(6):1622–7. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1847585
  28. Wake AD. The willingness to receive covid-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic†– a systematic review. Risk Manag Healthc Policy. 2021;14(March):2609–23.
  29. Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, et al. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine [Internet]. 2021;39(14):1968–76. Available from: https://doi.org/10.1016/j.vaccine.2021.02.060
  30. Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, et al. Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study. Vaccines [Internet]. 2021 Dec 10;9(12):1461. Available from: https://www.mdpi.com/2076-393X/9/12/1461
  31. Chang CT, Lim X-J, Chew C-C, Rajan P, Chan H-K, Abu Hassan MR, et al. Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country. Vaccine [Internet]. 2022 Dec;40(52):7515–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X22013342
  32. Zhou HJ, Pan L, Shi H, Luo JW, Wang P, Porter HK, et al. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Front Pharmacol [Internet]. 2022 Sep 20;13:1013485. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2022.1013485/full
  33. Tung T-H, Lin X-Q, Chen Y, Zhang M-X, Zhu J-S. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccin Immunother [Internet]. 2022 Jul 26;2099210. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2099210
  34. Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother [Internet]. 2020;16(9):2204–14. Available from: https://doi.org/10.1080/21645515.2020.1790279
  35. Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccines Immunother [Internet]. 2020;16(12):3074–80. Available from: https://doi.org/10.1080/21645515.2020.1819741
This article is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0). This license supports open dissemination, sharing, adaptation, and responsible reuse while preserving author ownership and requiring appropriate attribution.

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.